logo
09:19 Jun 11

Marksans Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
251.02
+4.10 (+1.66%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Marksans Pharma Ltd. Financials

Marksans Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
251.02
+4.10 (+1.66%)
09:19 Jun 11
Quality
image/svg+xml

73/100
High Financial Strength

Valuation
image/svg+xml

37/100
Mid Valuation

Technical

61/100
Technically Moderately Bullish

Strength

14

Weakness

4

Opportunity

1

Threats

0

13.82 %

ROE %

10.82 %

ROA %

9.22

EPS

66.71

BVPS

14.16 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
1490.84 1852.14 2177.41 2622.84 2950.94
Operating Expenses +
1231.95 1512.82 1718.83 2094.2 2350.17
Raw Material
703.92 927.75 1111.98 1327.5 1413.7
Increase Decrease in Cost
12.9 -6.39 -73.86 -183.76 -136.42
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
220.3 239.37 293.64 350.3 420.93
Miscellaneous Expenses
621.33 981.65 1275.63 1749.12 1560.94
Operating Profit
258.89 339.32 458.58 528.64 600.77
Other Income
41.85 59.31 50.42 70.38 82.53
Depreciation
44.78 51.85 74.27 83.39 98.63
Interest
8.45 9.13 11.2 11.66 24.12
Profit before tax and exceptio..
247.51 337.65 423.53 503.97 560.56
Exceptional Items
0 0 0 0 0
PBT
247.51 337.65 423.53 503.97 560.56
Provision for Taxation
60.7 72.33 108.63 121.35 140.49
Net Profit
186.81 265.32 314.9 382.62 420.06
NET Profit after MI
186.81 266.31 313.7 380.58 417.9
EPS
4.51 6.41 6.92 8.4 9.22
Operating Profit Margin (%)
17.37 18.32 21.06 20.16 20.36
Net Profit Margin (%)
12.53 14.38 14.41 14.51 14.16

Marksans Pharma Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 43.90 43.90 43.90 43.90 43.90 43.90
FII 16.80 8.10 16.90 19.90 22.20 22.00
Public 6.50 5.90 5.30 5.50 4.50 4.20
Others 32.80 42.10 33.90 30.70 29.40 29.90
Shareholder Shares Holding %
Research 360 logo
Download Our App On: